A new STAT examination has found that just a handful of networks of doctors, nurse practitioners, and physician assistants are writing prescriptions for the slew of websites offering the weight loss drugs, including the compounded versions that have been the subject of debate
Since it is introduced via the muscle, it is absorbed by the body quickly but will also provide a long-lasting natural energy-boosting effect
As evidence continues to evolve, integrating GLP1 therapies into holistic care plans can help clinicians deliver better outcomes for patients with diabetes and obesity
Most people want to know if it hurts, how fast they'll see changes, and whether it's actually safe
Global GLP-1 Receptor Agonist Market Recent Developments: 2025: Eli Lilly's once-daily oral GLP-1 agonist Orforglipron completed Phase III trials, delivering meaningful weight loss and strong blood-glucose (A1C) reduction